Albert Bourla: Pfizer CEO | Lex Fridman Podcast #249

18 Dec 2021 · 68 min
1:07:40

Long-form podcast interview (Lex Fridman with Albert Bourla, Pfizer CEO) focused on COVID-19 response: Bourla recounts the moment Pfizer learned Phase 3 vaccine results (Nov 8, 2020), explains why Pfizer "went all in" (company invested roughly $2.0–2.3 billion upfront), and describes how trials (phase I→III), manufacturing scale-up, and regulatory review were accelerated without changing trial standards. Major themes: balancing public good and corporate incentives; regulator transparency (FDA document-release dispute); restoring public trust in "Big Pharma" after past misconduct; vaccine safety, boosters, pediatric vaccination, and Paxlovid antiviral as a therapeutic game-changer; and communication challenges amid politicization and misinformation. The conversation closes on broader reflections about human ingenuity and mortality.

Chapters

More from LARRUZ

8:49
youtube.com

OpenAI’s New AI Is Doing Things We Barely Understand

3d ago
5:38
youtube.com

DeepSeek Solved AI’s Memory Problem

5d ago
33:17
youtube.com

DeepMind's New AI Just Cracked The Code Of Life

1w ago
3:43
youtube.com

The Billion Dollar AI Advantage Is Disappearing

1w ago
5:14
youtube.com

Claude Opus 5.5 AI: An Incredible Leap Forward

3w ago
5:16
youtube.com

Yes, Jev Is Insane, But There's A Catch

3w ago
5:11
youtube.com

DeepSeek’s Insane New Architecture

4w ago
4:16
youtube.com

Claude Is Now Leaving Invisible Fingerprints In Its Text

1mo ago
9:18
youtube.com

I Never Thought I’d See This Happen

1mo ago
5:22
youtube.com

GPT-6 Astra Changes Everything

1mo ago
4:55
youtube.com

Claude Fable AI Is Much Stranger Than The Headlines Suggest

1mo ago
See all content